Previous 10 | Next 10 |
Quest Diagnostics Prices $750 Million of Senior Notes PR Newswire SECAUCUS, N.J. , Oct. 30, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public o...
2023-10-25 08:15:55 ET More on market strategy SPY: Major Market Correction May Be Imminent SPY: 'Double-Barreled' Buy Signal Flashes SPY: The S&P 500 Has 15% (At Least) More Downside Ahead Earnings misses are being punished a lot more than beats are bein...
2023-10-25 08:10:11 ET More on Quest Diagnostics Quest Diagnostics: Moving Past Covid Quest Diagnostics Inc. (DGX) Q3 2023 Earnings Call Transcript Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues Quest Di...
Diadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer's Disease Prognostic Technology PR Newswire —Quest to Develop and Market a Lab-developed Test Based on the IP of AlzoSure Predict ® in the ...
2023-10-25 05:23:57 ET Summary Today, we take a look at Quest Diagnostics, a large testing and diagnostic concern that just reported Q3 results. Although the top and bottom line numbers slightly beat estimates, the stock is unlikely to get much of a bump out of results. The co...
2023-10-24 13:09:08 ET Quest Diagnostics Inc. (DGX) Q3 2023 Results Conference Call October 24, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR Jim Davis - Chairman, President & CEO Sam Samad - CFO Conference Call Participants Ann Hynes ...
NORTHAMPTON, MA / ACCESSWIRE / October 24, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 Through 4 priority areas, we focus on the hire-to-retire journey of our workforce by: Enhancing the employee experience and the future of how w...
UBS Group AG Registered (UBS) is expected to report for Q3 2023 Capital City Bank Group (CCBG) is expected to report $0.83 for Q3 2023 Boyd Gaming Corporation (BYD) is expected to report $1.44 for Q3 2023 Armstrong World Industries Inc (AWI) is expected to report $1.3 for Q3 2023 ...
2023-10-24 06:45:58 ET More on Quest Diagnostics Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues Quest Diagnostics, Inc. (DGX) Q2 2023 Earnings Call Transcript Quest Diagnostics Q3 2023 Earnings Preview S...
Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 PR Newswire Third quarter revenues of $2.30 billion , down 7.7% from 2022 Third quarter reported diluted earnings per share ("EPS") of $1.96 , down 9.7% fr...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...